Dosing antiretroviral medication when crossing time zones: a review.

AIDS

aTropical and Infectious Diseases Unit, Royal Liverpool University Hospital bWellcome Trust Liverpool Glasgow Centre for Global Health Research, University of Liverpool, Liverpool, UK cEuropean AIDS Treatment Group, Brussels, Belgium dDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool eSt Stephen's Centre, Chelsea & Westminster Foundation Trust, London, UK.

Published: January 2016

AI Article Synopsis

Article Abstract

International tourism continues to increase worldwide, and people living with HIV and their clinicians are increasingly confronted with the problem of how to dose antiretroviral therapy during transmeridian air travel across time zones. No guidance on this topic currently exists. This review is a response to requests from patient groups for clear, practical and evidence-based guidance for travelling on antiretroviral therapy; we present currently available data on the pharmacokinetic forgiveness and toxicity of various antiretroviral regimens, and synthesize this data to provide guidelines on how to safely dose antiretrovirals when travelling across time zones.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697953PMC
http://dx.doi.org/10.1097/QAD.0000000000000920DOI Listing

Publication Analysis

Top Keywords

time zones
12
antiretroviral therapy
8
dosing antiretroviral
4
antiretroviral medication
4
medication crossing
4
crossing time
4
zones review
4
review international
4
international tourism
4
tourism continues
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!